selected publications
-
academic article
- BCL-XL Overexpression Protects Pancreatic ß-Cells against Cytokine- and Palmitate-Induced Apoptosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 5657. 2023
- Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-ßH1 ß-cells against proinflammatory insults. FRONTIERS IN IMMUNOLOGY. 126392-126393. 2023
- G protein-coupled estrogen receptor activation by bisphenol-A disrupts the protection from apoptosis conferred by the estrogen receptors ER¿ and ERß in pancreatic beta cells. ENVIRONMENT INTERNATIONAL. 107250-107262. 2022
-
chapter
- Type I interferons as key players in pancreatic ß-cell dysfunction in type 1 diabetes. International Review of Cell and Molecular Biology. 1-80. 2021
-
congress communication
- DESARROLLO Y OPTIMIZACIÓN DE UN INHIBIDOR PEPTÍDICO PARA EL TRATAMIENTO PREVENTIVO DE LA DIABETES TIPO 1 2023
- DEUCRAVACITINIB, UN INHIBIDOR DEL DOMINIO PSEUDOQUINASA DE LA TIROSINA QUINASA 2 (TYK2), PROTEGE A LAS CÉLULAS BETA HUMANAS FRENTE A AGRESIONES PROINFLAMATORIAS 2023
- Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human ß c ells against proinflammatory insults 2023
- IFN¿ exposure affects Ca2+ signaling and hormone secretion in pancreatic alpha- and beta-cells 2023
- Small-molecule inhibitors of protein-protein interaction between TYK2 and IFNAR1 as a new strategy to prevent inflammation in early type 1 diabetes 2023
- Small-molecule inhibitors of protein-protein interaction between TYK2 and IFNAR1 as a new strategy to prevent inflammation in early type 1 diabetes 2023
- Efecto del IFN¿ en la función de las células ¿ y ß pancreáticas 2022
- G protein-coupled estrogen receptor activation by Bisphenol-A disrupts protection from apoptosis conferred by estrogen receptors ER¿ and ERß in pancreatic beta cells 2022
- GRUPO EXPERIMENTACIÓN BÁSICA EN DIABETES DE LA SED: Vimentin as a regulator of cell survival and endoplasmic reticulum stress in pancreatic ¿- and ß-cells 2022
- IDENTIFICACIÓN DE NUEVAS DIANAS TERAPÉUTICAS PARA EL TRATAMIENTO DE LA DIABETES TIPO 1 BASADAS EN LAS ESTRATEGIAS DE SUPERVIVENCIA DE LAS CÉLULAS ALFA PANCREÁTICAS 2022
- LA SOBREEXPRESIÓN DE BCL-XL COMO ESTRATEGIA PARA PROTEGER A LAS CÉLULAS BETA PANCREÁTICAS DE LA APOPTOSIS INDUCIDA POR CITOQUINAS PROINFLAMATORIAS EN LA DIABETES TIPO 1 2022
- Papel de los receptores de estrógenos en la apoptosis de la célula ß pancreática 2022
- Vimentin as a regulator of cell survival and endoplasmic reticulum stress in pancreatic alpha and beta cells. 1-469. 2022
- Vimentin as a regulator of cell survival and endoplasmic reticulum stress in pancreatic alpha- and beta-cells 2022
- Identification of new therapeutic targets for the treatment of type 1 diabetes based on the survival strategies of pancreatic alpha cells. 1-380. 2021
- Identification of new therapeutic targets for the treatment of type 1 diabetes based on the survival strategies of pancreatic alpha-cells 2021
- Pancreatic ß-cell viability tests aimed to identify diabetogenic chemicals 2021
- Role of estrogen receptors on pancreatic beta cell survival under apoptotic stress 2021
- The effect of endocrine disruptor Bisphenol-A on ion channel regulation and its relationship with apoptosis in the human beta cell line EndoC-bH1 2021
- The effect of the endocrine disruptor Bisphenol-A on ion channel regulation and its relationship with apoptosis in the human beta cell line EndoC-BH1 2021
- BCL-XL, PERO NO EL COMPLEMENTO C3, PROTEGE A LAS CÉLULAS ALFA CONTRA EL ESTRÉS METABÓLICO O LA APOPTOSIS INDUCIDA POR INFLAMACIÓN 2020
- Efecto de la sobreexpresión de BCL-XL en la función y supervivencia de la célula ß pancreática. 2020
- Descubrimiento de nuevas dianas terapéuticas para el tratamiento de la diabetes tipo 1 y tipo 2 basadas en las estrategias de supervivencia de la célula ¿ pancreática. 2019